| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 23 | 2025 | 3869 | 1.460 |
Why?
|
| Hydrocephalus | 3 | 2024 | 289 | 0.940 |
Why?
|
| Arnold-Chiari Malformation | 2 | 2024 | 54 | 0.900 |
Why?
|
| Skull Base Neoplasms | 1 | 2022 | 37 | 0.750 |
Why?
|
| Neural Tube Defects | 1 | 2024 | 378 | 0.640 |
Why?
|
| Pons | 2 | 2024 | 34 | 0.560 |
Why?
|
| Leukoencephalopathies | 2 | 2018 | 63 | 0.530 |
Why?
|
| Neuroimaging | 8 | 2025 | 398 | 0.520 |
Why?
|
| Contrast Media | 6 | 2022 | 493 | 0.500 |
Why?
|
| Societies, Medical | 6 | 2022 | 794 | 0.460 |
Why?
|
| Neoplastic Syndromes, Hereditary | 2 | 2026 | 85 | 0.440 |
Why?
|
| Child | 32 | 2026 | 26214 | 0.430 |
Why?
|
| Neck Injuries | 1 | 2014 | 22 | 0.420 |
Why?
|
| White Matter | 2 | 2025 | 224 | 0.410 |
Why?
|
| Angiography | 1 | 2014 | 187 | 0.400 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2013 | 83 | 0.400 |
Why?
|
| Diagnostic Imaging | 3 | 2026 | 301 | 0.400 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 599 | 0.380 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2015 | 358 | 0.380 |
Why?
|
| Brain Stem | 2 | 2022 | 110 | 0.370 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2014 | 214 | 0.360 |
Why?
|
| Vestibular Nerve | 1 | 2011 | 1 | 0.350 |
Why?
|
| Brain | 6 | 2025 | 3222 | 0.350 |
Why?
|
| Nervous System Malformations | 1 | 2011 | 136 | 0.310 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2011 | 154 | 0.310 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2022 | 2104 | 0.300 |
Why?
|
| Brain Injuries | 2 | 2025 | 709 | 0.300 |
Why?
|
| Humans | 48 | 2026 | 130776 | 0.290 |
Why?
|
| Diagnosis, Differential | 9 | 2025 | 1896 | 0.290 |
Why?
|
| Evidence-Based Medicine | 6 | 2022 | 643 | 0.280 |
Why?
|
| Craniocerebral Trauma | 2 | 2020 | 142 | 0.280 |
Why?
|
| Sinusitis | 2 | 2020 | 116 | 0.280 |
Why?
|
| Epilepsy | 1 | 2015 | 878 | 0.270 |
Why?
|
| Infant | 14 | 2025 | 13323 | 0.270 |
Why?
|
| Inflammation | 1 | 2015 | 1490 | 0.260 |
Why?
|
| Retrospective Studies | 15 | 2025 | 17674 | 0.250 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2015 | 1175 | 0.240 |
Why?
|
| Demyelinating Diseases | 2 | 2018 | 69 | 0.230 |
Why?
|
| Pediatrics | 1 | 2015 | 1242 | 0.230 |
Why?
|
| Child, Preschool | 15 | 2025 | 15011 | 0.230 |
Why?
|
| Near Drowning | 1 | 2025 | 30 | 0.230 |
Why?
|
| Cranial Nerves | 1 | 2024 | 21 | 0.220 |
Why?
|
| Seizures | 3 | 2025 | 885 | 0.220 |
Why?
|
| Brain Neoplasms | 3 | 2022 | 1307 | 0.220 |
Why?
|
| Skull | 2 | 2022 | 153 | 0.210 |
Why?
|
| Skull Base | 1 | 2024 | 48 | 0.210 |
Why?
|
| Tuberculosis, Spinal | 1 | 2023 | 9 | 0.210 |
Why?
|
| Tuberculosis, Central Nervous System | 1 | 2023 | 11 | 0.210 |
Why?
|
| Actinomycetaceae | 1 | 2023 | 5 | 0.200 |
Why?
|
| Actinomycosis | 1 | 2023 | 8 | 0.200 |
Why?
|
| Empyema | 1 | 2023 | 23 | 0.200 |
Why?
|
| Hysterotomy | 1 | 2024 | 141 | 0.200 |
Why?
|
| Laparotomy | 1 | 2024 | 140 | 0.200 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2003 | 17 | 0.200 |
Why?
|
| Tuberculosis, Meningeal | 1 | 2023 | 31 | 0.200 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2003 | 24 | 0.200 |
Why?
|
| Globus Pallidus | 1 | 2003 | 68 | 0.200 |
Why?
|
| Basal Ganglia | 1 | 2003 | 59 | 0.200 |
Why?
|
| Surface Plasmon Resonance | 1 | 2022 | 54 | 0.190 |
Why?
|
| Heart Defects, Congenital | 1 | 2015 | 1905 | 0.190 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2023 | 68 | 0.190 |
Why?
|
| Female | 22 | 2025 | 70630 | 0.190 |
Why?
|
| Anti-N-Methyl-D-Aspartate Receptor Encephalitis | 1 | 2023 | 50 | 0.180 |
Why?
|
| Fourth Ventricle | 1 | 2022 | 9 | 0.180 |
Why?
|
| Survivorship | 1 | 2022 | 45 | 0.180 |
Why?
|
| Tinnitus | 1 | 2022 | 23 | 0.180 |
Why?
|
| Cerebellar Ataxia | 1 | 2022 | 62 | 0.180 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2023 | 256 | 0.170 |
Why?
|
| Anemia | 1 | 2025 | 355 | 0.170 |
Why?
|
| Dermoid Cyst | 1 | 2021 | 36 | 0.170 |
Why?
|
| Scalp | 1 | 2021 | 58 | 0.170 |
Why?
|
| Prognosis | 3 | 2024 | 4934 | 0.170 |
Why?
|
| Meningomyelocele | 1 | 2024 | 281 | 0.170 |
Why?
|
| Proton Therapy | 1 | 2022 | 158 | 0.170 |
Why?
|
| Medical Oncology | 1 | 2022 | 238 | 0.170 |
Why?
|
| Male | 21 | 2025 | 64680 | 0.170 |
Why?
|
| Malignant Atrophic Papulosis | 1 | 2020 | 4 | 0.160 |
Why?
|
| Paranasal Sinuses | 1 | 2020 | 18 | 0.160 |
Why?
|
| Radiology Department, Hospital | 1 | 2020 | 25 | 0.160 |
Why?
|
| Mitochondrial Diseases | 1 | 2022 | 149 | 0.160 |
Why?
|
| Fetoscopy | 1 | 2024 | 481 | 0.160 |
Why?
|
| Streptococcal Infections | 1 | 2022 | 252 | 0.160 |
Why?
|
| Anti-Infective Agents | 1 | 2022 | 265 | 0.160 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2020 | 50 | 0.150 |
Why?
|
| Hematoma, Subdural | 1 | 2019 | 28 | 0.150 |
Why?
|
| Head and Neck Neoplasms | 1 | 2025 | 636 | 0.150 |
Why?
|
| Cerebrovascular Disorders | 1 | 2020 | 113 | 0.150 |
Why?
|
| Infant, Newborn | 7 | 2024 | 8567 | 0.150 |
Why?
|
| Spinal Injuries | 1 | 2019 | 33 | 0.150 |
Why?
|
| Meningitis, Viral | 1 | 2018 | 10 | 0.150 |
Why?
|
| Branchio-Oto-Renal Syndrome | 1 | 2018 | 11 | 0.150 |
Why?
|
| Central Nervous System Viral Diseases | 1 | 2018 | 13 | 0.140 |
Why?
|
| Temporal Bone | 2 | 2018 | 37 | 0.140 |
Why?
|
| Myelitis | 1 | 2018 | 14 | 0.140 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2023 | 179 | 0.140 |
Why?
|
| Neuromuscular Diseases | 1 | 2018 | 44 | 0.140 |
Why?
|
| Cochlea | 1 | 2018 | 88 | 0.140 |
Why?
|
| Polyneuropathies | 1 | 2018 | 31 | 0.130 |
Why?
|
| Ipilimumab | 1 | 2018 | 62 | 0.130 |
Why?
|
| West Nile virus | 1 | 2018 | 119 | 0.130 |
Why?
|
| Betacoronavirus | 1 | 2020 | 285 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2018 | 364 | 0.130 |
Why?
|
| West Nile Fever | 1 | 2018 | 140 | 0.130 |
Why?
|
| Child Abuse | 1 | 2019 | 221 | 0.120 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2018 | 124 | 0.120 |
Why?
|
| Pregnancy | 3 | 2024 | 7499 | 0.120 |
Why?
|
| Temporomandibular Joint Disorders | 1 | 2016 | 12 | 0.120 |
Why?
|
| Nervous System Diseases | 1 | 2020 | 397 | 0.120 |
Why?
|
| Chromosome Deletion | 1 | 2018 | 651 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 364 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 375 | 0.110 |
Why?
|
| Hearing Loss, Unilateral | 1 | 2014 | 9 | 0.110 |
Why?
|
| Lateral Sinus Thrombosis | 1 | 2014 | 3 | 0.110 |
Why?
|
| Transverse Sinuses | 1 | 2014 | 2 | 0.110 |
Why?
|
| Hearing Aids | 1 | 2014 | 30 | 0.110 |
Why?
|
| Adolescent | 8 | 2025 | 20832 | 0.110 |
Why?
|
| Vertebral Artery | 1 | 2014 | 19 | 0.110 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2014 | 84 | 0.100 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2013 | 8 | 0.100 |
Why?
|
| Glasgow Coma Scale | 1 | 2014 | 203 | 0.100 |
Why?
|
| Accidents, Traffic | 1 | 2014 | 105 | 0.100 |
Why?
|
| Prenatal Diagnosis | 1 | 2018 | 650 | 0.100 |
Why?
|
| Optic Nerve Diseases | 1 | 2014 | 80 | 0.100 |
Why?
|
| Neck | 1 | 2014 | 143 | 0.100 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2013 | 47 | 0.100 |
Why?
|
| Pandemics | 1 | 2020 | 1158 | 0.100 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2013 | 167 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 379 | 0.090 |
Why?
|
| Audiometry | 1 | 2011 | 20 | 0.090 |
Why?
|
| Sampling Studies | 1 | 2011 | 74 | 0.090 |
Why?
|
| Ataxia | 2 | 2022 | 157 | 0.080 |
Why?
|
| Melanoma | 1 | 2018 | 920 | 0.080 |
Why?
|
| Cochlear Implantation | 1 | 2011 | 54 | 0.080 |
Why?
|
| Survivors | 2 | 2022 | 348 | 0.080 |
Why?
|
| Risk Factors | 2 | 2015 | 11003 | 0.080 |
Why?
|
| Rare Diseases | 1 | 2011 | 210 | 0.070 |
Why?
|
| Organometallic Compounds | 2 | 2013 | 111 | 0.070 |
Why?
|
| Cytokines | 1 | 2015 | 1339 | 0.070 |
Why?
|
| Syndrome | 1 | 2011 | 1161 | 0.070 |
Why?
|
| United States | 5 | 2021 | 11834 | 0.060 |
Why?
|
| Electroencephalography | 1 | 2011 | 861 | 0.060 |
Why?
|
| Neurofibromatosis 2 | 1 | 2026 | 12 | 0.060 |
Why?
|
| Hamartoma Syndrome, Multiple | 1 | 2026 | 24 | 0.060 |
Why?
|
| von Hippel-Lindau Disease | 1 | 2026 | 20 | 0.060 |
Why?
|
| Multiple Endocrine Neoplasia | 1 | 2026 | 25 | 0.060 |
Why?
|
| Beckwith-Wiedemann Syndrome | 1 | 2026 | 20 | 0.060 |
Why?
|
| Gray Matter | 1 | 2025 | 51 | 0.060 |
Why?
|
| Biomarkers | 1 | 2015 | 3400 | 0.060 |
Why?
|
| Neurofibromatosis 1 | 1 | 2026 | 71 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2026 | 3417 | 0.050 |
Why?
|
| Meninges | 1 | 2023 | 22 | 0.050 |
Why?
|
| Prospective Studies | 1 | 2015 | 6494 | 0.050 |
Why?
|
| Heterocyclic Compounds | 1 | 2003 | 17 | 0.050 |
Why?
|
| Glutaryl-CoA Dehydrogenase | 1 | 2003 | 4 | 0.050 |
Why?
|
| Gadolinium DTPA | 1 | 2003 | 49 | 0.050 |
Why?
|
| Joint Diseases | 1 | 2003 | 32 | 0.050 |
Why?
|
| Spin Labels | 1 | 2023 | 24 | 0.050 |
Why?
|
| Hashimoto Disease | 1 | 2023 | 29 | 0.050 |
Why?
|
| Streptococcus gallolyticus | 1 | 2022 | 3 | 0.050 |
Why?
|
| Gadolinium | 1 | 2003 | 111 | 0.050 |
Why?
|
| Verbal Learning | 1 | 2022 | 67 | 0.050 |
Why?
|
| Streptococcus | 1 | 2022 | 63 | 0.050 |
Why?
|
| Intelligence Tests | 1 | 2022 | 62 | 0.050 |
Why?
|
| Protons | 1 | 2022 | 98 | 0.050 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2023 | 133 | 0.050 |
Why?
|
| Encephalitis | 1 | 2023 | 120 | 0.040 |
Why?
|
| Penicillins | 1 | 2022 | 154 | 0.040 |
Why?
|
| Spinal Cord | 1 | 2023 | 264 | 0.040 |
Why?
|
| Organizational Objectives | 1 | 2020 | 35 | 0.040 |
Why?
|
| Gestational Age | 1 | 2024 | 1229 | 0.040 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2020 | 62 | 0.040 |
Why?
|
| Biological Factors | 1 | 2020 | 26 | 0.040 |
Why?
|
| Cranial Nerve Diseases | 1 | 2020 | 28 | 0.040 |
Why?
|
| Personal Protective Equipment | 1 | 2020 | 52 | 0.040 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2020 | 44 | 0.040 |
Why?
|
| Multiple Sclerosis | 1 | 2003 | 389 | 0.040 |
Why?
|
| Urinary Incontinence | 1 | 2020 | 69 | 0.040 |
Why?
|
| Hospitals | 1 | 2022 | 436 | 0.040 |
Why?
|
| Nitriles | 1 | 2020 | 162 | 0.040 |
Why?
|
| Headache | 1 | 2020 | 109 | 0.040 |
Why?
|
| Workplace | 1 | 2020 | 81 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2020 | 364 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2022 | 961 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2014 | 2126 | 0.040 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2018 | 89 | 0.040 |
Why?
|
| 14-3-3 Proteins | 1 | 2018 | 57 | 0.040 |
Why?
|
| Cerebellum | 1 | 2022 | 441 | 0.040 |
Why?
|
| Cerebral Aqueduct | 1 | 2018 | 10 | 0.030 |
Why?
|
| Adult | 4 | 2023 | 31269 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2020 | 275 | 0.030 |
Why?
|
| Family | 1 | 2021 | 586 | 0.030 |
Why?
|
| Herpesvirus 4, Human | 1 | 2020 | 644 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2018 | 249 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2020 | 356 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2025 | 1212 | 0.030 |
Why?
|
| Skin | 1 | 2020 | 547 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2020 | 450 | 0.030 |
Why?
|
| Cognition | 1 | 2022 | 817 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2020 | 1164 | 0.030 |
Why?
|
| Mitochondria | 1 | 2022 | 760 | 0.030 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 566 | 0.030 |
Why?
|
| Meningeal Neoplasms | 1 | 2018 | 210 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2024 | 5230 | 0.030 |
Why?
|
| Suture Anchors | 1 | 2014 | 1 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2024 | 12910 | 0.030 |
Why?
|
| Fetus | 1 | 2018 | 584 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2014 | 241 | 0.030 |
Why?
|
| Texas | 1 | 2022 | 3634 | 0.030 |
Why?
|
| Optic Disk | 1 | 2014 | 46 | 0.030 |
Why?
|
| Disease Progression | 1 | 2020 | 2202 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2014 | 229 | 0.030 |
Why?
|
| Observer Variation | 1 | 2014 | 317 | 0.030 |
Why?
|
| Meglumine | 1 | 2013 | 16 | 0.030 |
Why?
|
| Subtraction Technique | 1 | 2013 | 36 | 0.030 |
Why?
|
| Optic Nerve | 1 | 2014 | 114 | 0.020 |
Why?
|
| Random Allocation | 1 | 2013 | 422 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2014 | 614 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 5089 | 0.020 |
Why?
|
| Prevalence | 1 | 2014 | 2684 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 2937 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 2307 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2014 | 3418 | 0.020 |
Why?
|
| Middle Aged | 2 | 2020 | 28499 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 6784 | 0.010 |
Why?
|
| Aged | 1 | 2013 | 20958 | 0.010 |
Why?
|